Repeat knee osteoarthritis treatment with Conjuran injections
Part of Bones, joints & muscles clinical trials.
This trial tests whether repeating Conjuran injections into the knee helps reduce pain and improves function in people with moderate knee osteoarthritis. The study tracks safety and effectiveness after the first and second treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 40 years or older
- Knee osteoarthritis confirmed by a doctor using standard diagnostic criteria
- Mild to moderate osteoarthritis (Kellgren-Lawrence grade I–III)
- Meaningful knee pain when standing or walking (VAS score of 40 mm or higher on a 100 mm scale)
- No active inflammation from other types of arthritis in the knee
- Not pregnant or breastfeeding, and not enrolled in another clinical trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called NPNP-001 for people with knee osteoarthritis who have not gotten enough relief from other treatments. The medicine is given as an injection into the knee to see if it can reduce pain and improve function.
This trial tests a new injectable filler called ALLOHEAL, injected directly into the knee joint to reduce pain and improve function in people with knee osteoarthritis. The filler is designed to cushion the knee joint and may help reduce pain and stiffness.
This study tests whether a hyaluronic acid injection (a natural lubricant for joints) can reduce inflammation markers in the knee for people with osteoarthritis. It may be a good option if you have moderate knee pain that hasn't improved with other treatments.
This study tests a new knee injection called CX-011 to see if it can reduce pain and improve function in people with knee osteoarthritis. It may be a good option if you have tried other treatments without enough relief.
This study tests the safety of an experimental injection called OA-SYS for people with moderate to severe knee osteoarthritis. It may help if you have not had recent injections or certain other health problems.
This study tests a new injection called 2107 to see if it helps reduce pain and improve function in people with mild to moderate knee osteoarthritis. If you're eligible, you'll receive the injection and be monitored for several months to see how it works.
Hear when a new Knee Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.